Company Overview and News
2018-07-18 seekingalpha - 14
Amazon.com, Visa Inc., Apple Inc., Alibaba Group Holdings, and Microsoft are the largest five individual stock positions.
UNLNF HSB SCGLF LLOBF ABLZF CSCO TCTZF GE COF-P VOD SCGLY PBR DDAIF AAWW 500180 MSFT NTES RIO WST AXP LEN.B COF-D COF-C COF-F HEI RTNTF ACA FAF BIDU HBCYF ASML UL VOD UN BHPBF LLY GSK 0005 HDB GNE BHP 8035 TV SSYS VRNT AZN VALE3 FCX SIVB TOELY 6506 6503 VSH PEGA TOELF SMG SLB SMSN VECO PFIZER HCS HEI.A CFRUY RJD SCL SLB PFE RJF SMSD JD HD SSNLF SMFG UBS DG HDFCBANK HSBC ABEV SNN LFUS COST COF MRAAY LECO TORO SNY V PEP VODPF MRK MRAAF LLD5 SU LLD7 LLD6 LLD1 DPZ LLD2 INGR RIO BLT ULVR BECN YASKY SAN SAM AMX MS TSM YASKF INFY UTX BABA NVO JNJ LLDTF NVS BHPLF AZPN BAP LEN WMGI CFRHF RTPPF CLGX BOE AAPL INTC BBVA KBH POOL LLOY ITUB CRARF TTC LLPH ING SAP LLPK MEL LLPJ LLPE JPM LLPD LLPG HSEA HSEB LLPC CRARY 500680 ULSGF SMCAY BCS XOM CTRP SEM WMT AMZN TCEHY ASML UNLYF SF BC94 BBD STE BRK.A GOOGL RIO BBL GLE BA EWBC PG NTCT YELP GOOG HRC CHE ASX ORCL QRVO PFZ BUD GEC MIELF SFN LYG UMPQ ABB VALE BHP MIELY CVX OCLCF SFB
2018-04-27 seekingalpha - 4
Amazon.com, Alibaba Group Holdings, Visa Inc., Apple Inc., and Taiwan Semiconductor Manufacturing are the largest five individual stock positions.
BNPQY UNLNF LLOBF ABLZF CSCO ABBV GE COF-P VOD HXSCF SCGLY PBR DDAIF AAWW 500180 MSFT NTES HXSCL WST AXP LEN.B COF-D COF-C COF-F HEI FAF RYDAF BIDU TATAMOTORS ASML UL UN LLY GSK DPSGY ICICIBANK HDB GNE TV SSYS VRNT AZN RDSB SIVB RDSA 6506 6503 VSH PEGA CMCSK SAN SMG CAVM SBGSY SMSN VECO PFIZER HEI.A CFRUY RYDBF RJD ABBV PFE RJF SMSD JD HD SSNLF SIEGY SMFG SMFNF GS UBS DG HDFCBANK HSBC ABEV LFUS FANUF SNN CMCSA COST COF LECO TORO SNY V BLK PEP ETFC MRK 532174 LLD5 LLD7 LLD6 LLD1 DPZ LLD2 INGR ULVR BECN YASKY SAN AMX MS 500570 TSM YASKF INFY UTX VCISY BABA MTH NVO JNJ LAZ LLDTF NVS BASFY AZPN BAP CCV LEN WMGI CCZ CLGX BOE AAPL INTC SFTBY KSU BBVA KBH POOL LLOY MA ITUB PACW LVMUY TTC LLPH ING SAP LLPK MEL LLPJ LLPE JPM LLPD 8316 LLPG CCV.CL RHHBY LLPC CRARY 500680 TTM SMCAY BCS XOM CTRP SEM WMT AMZN GSK ASML UNLYF SF BC94 WTFCW WTFC STE BBD BRK.A WTFCM GOOGL INFY MKSI BA EWBC PG NTCT YELP HRC GOOG CHE RDY ASX ORCL DIS QRVO PFZ BUD RDS.B GEC RDS.A IBN MIELF SFN LYG UMPQ WTFPP DPSTF ABB AZN MIELY CVX OCLCF SAN SFB
Les données d'activité du premier trimestre 2018, en dépit de conditions climatiques difficiles en Europe, confirment les bonnes tendances observées en 2017 et confortent la perspective de hausses du chiffre d'affaires et des résultats du Groupe pour l'ensemble de l'année.
SAO PAULO (Reuters) - United Arab Emirates’ sovereign wealth fund Mubadala Development Co [MUDEV.UL] is keen to acquire a majority stake in Brazilian suburban rail operator Supervia, controlled by conglomerate Odebrecht SA, three sources with knowledge of the matter said.
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to EPA:DG / VINCI on message board site Silicon Investor.